abstract |
The present invention is related to compounds having the formula (I), wherein R1, R2, R3, R4, R5, X1, X2, T, U, V, W, Y and n are as defined in the claims, pharmaceutical compositions comprising the compounds and the use of the compounds for manufacturing a medicament for the use in the treatment of diseases involving an abnormal cell proliferation, an undesired cell proliferation, an abnormal mitosis and/or an undesired mitosis, the disease being selected from neurodegenerative diseases, stroke, inflammatory diseases, immune based disorders, infectious diseases, heart diseases, cardiovascular diseases and cell proliferative diseases. |